These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 15639783)

  • 1. Neuroprotective strategies for HIV-1 associated dementia.
    Dou H; Kingsley JD; Mosley RL; Gelbard HA; Gendelman HE
    Neurotox Res; 2004; 6(7-8):503-21. PubMed ID: 15639783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.
    Power C; Gill MJ; Johnson RT
    Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective activities of CEP-1347 in models of neuroAIDS.
    Eggert D; Dash PK; Gorantla S; Dou H; Schifitto G; Maggirwar SB; Dewhurst S; Poluektova L; Gelbard HA; Gendelman HE
    J Immunol; 2010 Jan; 184(2):746-56. PubMed ID: 19966207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.
    Ryan LA; Cotter RL; Zink WE; Gendelman HE; Zheng J
    Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):137-50. PubMed ID: 11995633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.
    Anderson E; Zink W; Xiong H; Gendelman HE
    J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S43-54. PubMed ID: 12394782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive therapies for HIV-1 associated neurologic disease.
    Perry SW; Norman JP; Gelbard HA
    Neurotox Res; 2005 Oct; 8(1-2):161-6. PubMed ID: 16260393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis.
    Dou H; Birusingh K; Faraci J; Gorantla S; Poluektova LY; Maggirwar SB; Dewhurst S; Gelbard HA; Gendelman HE
    J Neurosci; 2003 Oct; 23(27):9162-70. PubMed ID: 14534250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons.
    Sui Z; Sniderhan LF; Fan S; Kazmierczak K; Reisinger E; Kovács AD; Potash MJ; Dewhurst S; Gelbard HA; Maggirwar SB
    Eur J Neurosci; 2006 May; 23(10):2623-34. PubMed ID: 16817865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS.
    Dewhurst S; Maggirwar SB; Schifitto G; Gendelman HE; Gelbard HA
    J Neuroimmune Pharmacol; 2007 Mar; 2(1):93-6. PubMed ID: 18040831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes.
    Zheng J; Gendelman HE
    Curr Opin Neurol; 1997 Aug; 10(4):319-25. PubMed ID: 9266156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia.
    Persidsky Y; Zheng J; Miller D; Gendelman HE
    J Leukoc Biol; 2000 Sep; 68(3):413-22. PubMed ID: 10985259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin.
    Kaul M; Lipton SA
    Neurotox Res; 2005 Oct; 8(1-2):167-86. PubMed ID: 16260394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions.
    Swindells S; Zheng J; Gendelman HE
    AIDS Patient Care STDS; 1999 Mar; 13(3):153-63. PubMed ID: 10375263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1-associated dementia: a basic science and clinical perspective.
    Diesing TS; Swindells S; Gelbard H; Gendelman HE
    AIDS Read; 2002 Aug; 12(8):358-68. PubMed ID: 12229893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving paradigms in the pathogenesis of HIV-1-associated dementia.
    Fischer-Smith T; Rappaport J
    Expert Rev Mol Med; 2005 Dec; 7(27):1-26. PubMed ID: 16321172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective therapy for HIV dementia.
    Turchan J; Sacktor N; Wojna V; Conant K; Nath A
    Curr HIV Res; 2003 Oct; 1(4):373-83. PubMed ID: 15049424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.
    Persidsky Y; Gendelman HE
    J Leukoc Biol; 2003 Nov; 74(5):691-701. PubMed ID: 14595004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.
    Navia BA; Rostasy K
    Neurotox Res; 2005 Oct; 8(1-2):3-24. PubMed ID: 16260383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-associated central nervous system dysfunction.
    Krebs FC; Ross H; McAllister J; Wigdahl B
    Adv Pharmacol; 2000; 49():315-85. PubMed ID: 11013768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.
    Grovit-Ferbas K; Harris-White ME
    Immunol Res; 2010 Dec; 48(1-3):40-58. PubMed ID: 20725864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.